Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the garnet study

Featured Printed Posters (Poster Rounds with the Professors)(2022)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要